Table 1. Identification of Myc Cofactors in mESCs by Co-Immunoprecipitation and Tandem Mass Spectrometry.
Gene Symbol | Gene Name | Peptide # (N-N-c-c- Myc co-IP) |
Peptide # Control (No Antibody) |
Total Percent Peptide Coverage |
Range of Percent Probability |
Known Myc Cofactors (Cell Type) |
---|---|---|---|---|---|---|
Eef1a1 | Eukaryotic translation elongation factor 1 alpha 1 | 0-0-6-5 | 0-0 | 16 | 60–95 | |
Ddx20 | DEAD box polypeptide 20 | 0-0-4-3 | 0-0 | 10 | 50–95 | mESCs30 |
Hist1h2be | Histone cluster 1, H2be | 0-0-4-2 | 0-0 | 37 | 77–95 | |
Ruvbl2 | Ruvb-like protein 2 | 0-0-4-2 | 0-0 | 7 | 75–95 | mESCs31,32 |
H3f3b | H3 histone, family 3b | 0-0-3-3 | 0-0 | 25 | 65–95 | |
Npm1 | Nucleophosmin 1 | 0-3-3-0 | 0-0 | 11 | 81–95 | MEFs33 |
Ybx1 | V box protein 1 | 1-1-1-2 | 0-1 | 17 | 70–95 | mESCs30 |
hnrnpk | Heterogeneous nuclear ribonucleoprotein K |
0-0-5-0 | 0-0 | 8 | 61–95 | |
Hist1h1b | Histone cluster 1, H1b | 0-0-3-2 | 1-0 | 20 | 95 | |
Dppa4 | Developmental pluripotency associated 4 | 0-2-0-0 | 0-0 | 11 | 52–69 | |
Nono | Non-POU-domain- containing, octamer binding protein |
1-0-1-0 | 0-0 | 7 | 95 | |
Ctrnb1 | Catenin, beta 1 | 0-2-0-0 | 0-0 | 6 | 95 | |
Mycn | V-myc myelocytomatosis viral related oncogene, neuroblastoma derived |
0-0-1-1 | 0-0 | 10 | 80–90 | Control |
Hist1h1a | Histone cluster 1, H1a | 0-0-0-1 | 0-0 | 15 | 95 | |
Hist4h4 | Histone cluster 4, H4 | 0-0-1-0 | 0-0 | 12 | 94–95 | |
Utf1 | Undifferentiated embryonic cell transcription factor 1 |
0-0-0-1 | 0-0 | 5 | 95 | 95 |
Dnmt3a | DNA methyltransferase 3a | 1-0-0-0 | 0-0 | 2 | 76 | U2OS34 |